Keyphrases
Placebo
100%
Intraocular Pressure
100%
Dose-response
100%
Dose Duration
100%
Duration of Action
100%
Topical Carbonic Anhydrase Inhibitors
100%
Primary Open-angle Glaucoma
33%
Low Intraocular Pressure
33%
Randomized Placebo-controlled Trial
33%
Dose Effect
33%
Percentage Reduction
33%
Ocular Hypertension
33%
Carbonic Anhydrase Inhibitors
33%
Two-center
33%
Pressure Reduction
33%
Topical Administration
33%
Single Drop
33%
Medicine and Dentistry
Intraocular Pressure
100%
Placebo
100%
Dose Response
100%
Carbonate Dehydratase Inhibitor
100%
Open Angle Glaucoma
25%
Ocular Hypertension
25%
Single Drug Dose
25%
Topical Drug Administration
25%
Neuroscience
Placebo
100%
Intraocular Pressure
100%
Carbonic Anhydrase Inhibitor
100%
Ocular Hypertension
25%
Open-Angle Glaucoma
25%
Crossover Study
25%
Agricultural and Biological Sciences
Placebo
100%
Dose Response
100%
Carbonic Anhydrase Inhibitor
100%
Cross-over Studies
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Carbonate Dehydratase Inhibitor
100%
Open Angle Glaucoma
25%
Intraocular Hypertension
25%
Veterinary Science and Veterinary Medicine
Carbonic Anhydrase Inhibitor
100%